Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction

Chest

Volumn 125, Issue 3, 2004, Pages 823-830

  Yugar Toledo, Juan Carlos ^a   Tanus Santos, Jose Eduardo ^a,b   Sabha, Maricene ^a   Sousa, Márcio Gonçalves ^a   Cittadino, Máira ^a   Buonalumi Tácito, Lúcia Helena ^a   Moreno Jr , Heitor ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Fund Amparo Pesquisa Estado S P   (Brazil)

Author keywords

Diabetes mellitus; Endothelial function; Nicotine; Nitric oxide; Thromboxane; Vascular remodeling

Indexed keywords

CYCLIC GMP; GLYCERYL TRINITRATE; NITRATE; NITRIC OXIDE; NITRITE; THROMBOXANE B2;

ADULT; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; EVALUATION; HUMAN; HYPEREMIA; MEASUREMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; STATISTICAL SIGNIFICANCE; ULTRASOUND; VASCULAR DISEASE; VASODILATATION;

EID: 1642266546     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.823     Document Type: Article

References (50)

1. Kannel WB. Hypertension and other risk factors in coronary heart disease. Am Heart J 1987; 114:918-925
2. Turner RC, Millns H, Neil HAW, et al. Risk factor for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316:823-828
3. Nowak J, Murray JJ, Oates JA, et al. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987; 76:6-14
4. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 39:287-324
5. Elliott HL. Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? J Cardiovasc Pharmacol 1998; 32(Suppl 3):S74-S77
6. Stern M. Natural history of macro vascular disease in type 2 diabetes. Diabetes Care 1999; 22(Suppl 3):C2-C5
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809
8. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms, oxidation, inflammation and genetics. Circulation 1995; 91:2488-2496
9. Eckerl HR. Natural history of macro vascular disease and classic risk factor for atherosclerosis. Diabetes Care 1999; 22(Suppl 3):C21-C24
10. Poredos P, Orehek M, Tratnik E. Smoking is associated with dose-related increases of intima-media thickness and endothelial dysfunction. Angiology 1999; 50:201-208
11. Cosentino F, Lüscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 1998; 32(Suppl 3):S54-S61
12. Furchgott RF, Zawadzki JB. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376
13. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in men. Lancet 1989; 2:997-1000
14. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
15. Dattilo JB, Makhoul RG. The role of nitric oxide in vascular biology pathobiology. Ann Vasc Surg 1997; 11:307-314
16. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115
17. Sorensen KE, Celermajer DS, Spiegelhalter DS, et al. Non-invasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. Br Heart J 1995; 74:247-253
18. Adams MK, Robinson JNR, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32:123-127
19. Celermajer D, Sorensen KE, Georgakopolus D, et al. Cigarette smoking is associated with a dose dependent and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149-2155
20. Motoyama T, Kawano H, Kugiyama K, et al. Endothelium-dependent vasodilatation in the brachial artery is impaired in smokers: effect of vitamin C. Am J Physiol 1997; 273:H1644-H1650
21. Lekakis J, Papamichael C, Vemmos C, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997; 79:529-531
22. Goodfellow J, Ramsey MW, Luddington LA, et al. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ 1996; 312:744-745
23. Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27:567-574
24. Higashi Y, Tetsuya O, Nobuo I, et al. Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension 1997; 29:280-285
25. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27
26. Panza JA, Casino PR, Kilcoyne CM, et al. Role of the endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87:1468-1474
27. Iiyama K, Nagano M, Yo Y, et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 1996; 132:779-782
28. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91:1314-1319
29. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138
30. Moshage H, Kok B, Huizenga JR, et al. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995; 41:892-896
31. Murad F. Cyclic GMP: synthesis, metabolism, and function; introduction and some historical comments. Adv Pharmacol 1994; 26:1-5
32. 2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191. Circulation 1990; 81(Suppl 1):I42-I52
33. Moreno H Jr, Chalon S, Urae A, et al. Endothelial dysfunction in human hand veins is rapidly reversible after smoking cessation. Am J Physiol 1998; 275:H1040-H1045
34. Chalon S, Tejura B, Moreno H Jr, et al. Role of nitric oxide in isoprenaline and sodium nitroprusside-induced relaxation in human hand veins. Br J Clin Pharmacol 1999; 47:91-98
35. McVeigh GE, Lemay L, Morgan D, et al. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996; 78:668-672
36. Node K, Kitakaze M, Yoshikawa H, et al. Reversible reduction in plasma concentration of nitric oxide induced by cigarette smoking in young adults. Am J Cardiol 1997; 79:1538-1541
37. 2 formation without affecting platelet survival in young healthy females. Thromb Haemost 1992; 68:583-588
38. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 1998; 287:435-439
39. Bucala R, Tracy KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1992; 87:432-438
40. Singh R, Barden A, Mori T, et al. Advanced glycation end products: a review. Diabetologia 2001; 44:129-146
41. Tooke JE. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. J Diabetes Complicat 2000; 14:197-200
42. McVeigh GE, Brennan GM, Johnson GD, et al. Impaired endothelium- dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:771-776
43. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19:257-267
44. Honing ML, Morrison PJ, Banga JD, et al. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998; 14:241-249
45. Schaefer EJ, McNamara JR, Nakajima K, et al. Elevated remnant-like particle cholesterol and triglyceride levels in diabetics men and women in the Framingham Offspring Study. Diabetes Care 2002; 25:989-994
46. Tesfamarian B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992; 263:H321-H326
47. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997; 20(Suppl 2):II26-II33
48. Jiang L, Shao-Ping Z, Xiang-Ping L, et al. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997; 61:165-169
49. Forte P, Copland M, Smith LM, et al. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349:837-842
50. 2 and prostacyclin metabolites in young men. Circulation 1991; 83:1698-1704